Stockscreener 앱 받기
0.7471
2.93%
0.0213
전일 마감가:
$0.7258
열려 있는:
$0.7258
하루 거래량:
231.03K
Relative Volume:
0.70
시가총액:
$42.19M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-1.27%
1개월 성능:
-61.49%
6개월 성능:
-68.87%
1년 성능:
-83.51%
1일 변동 폭
$0.70
$0.7748
1주일 범위
$0.70
$0.7973
52주 변동 폭
$0.70
$5.50
Tuhura Biosciences Inc Stock (HURA) Company Profile
명칭
Tuhura Biosciences Inc
전화
813-875-6600
주소
10500 UNIVERSITY CENTER DR., TAMPA
HURA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HURA
Tuhura Biosciences Inc
|
0.7471 | 40.99M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.15 | 118.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
812.27 | 81.61B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.50 | 53.69B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.94 | 49.49B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.00 | 37.34B | 447.02M | -1.18B | -906.14M | -6.1812 |
Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-03 | 개시 | H.C. Wainwright | Buy |
| 2024-12-19 | 개시 | Rodman & Renshaw | Buy |
| 2024-11-05 | 개시 | Maxim Group | Buy |
Tuhura Biosciences Inc 주식(HURA)의 최신 뉴스
Why TuHURA Biosciences Inc. stock could see breakout soonMid Cap Growth Trends & Rapid Capital Gain - ulpravda.ru
TuHURA Biosciences Inc Stock Analysis and ForecastRetail Trading Trends & Enter Your Email to Get Stock Alerts - earlytimes.in
Tuhura Biosciences amends loan agreement, secures full $3M - MSN
Is TuHURA Biosciences Inc PL3 a good long term investmentStop Loss Placement Tips & Big Profit Small Investment - earlytimes.in
What the Latest News Means for ABS Marine Services Limited Stock InvestorsTake Profit Strategies & Free Tremendous Portfolio Expansion - earlytimes.in
TUHURA Biosciences announces $15.6M registered direct offering - MSN
What analysts say about TuHURA Biosciences Inc PL3 stockEvening Star Patterns & Don’t Miss These Undervalued Stocks - earlytimes.in
Analysts Offer Insights on Healthcare Companies: Actinogen Medical (OtherATGGF) and TuHURA Biosciences (HURA) - The Globe and Mail
Does TuHURA Biosciences Inc. stock trade at a discount to peers2025 Buyback Activity & Free Real-Time Market Sentiment Alerts - Улправда
Is TuHURA Biosciences Inc. stock supported by innovation pipelineTrend Reversal & Growth Focused Entry Point Reports - Улправда
Will TuHURA Biosciences Inc. (PL3) stock attract long term capital inflows2025 Technical Patterns & Expert Verified Movement Alerts - Улправда
Volume Summary: Does TuHURA Biosciences Inc. stock trade at a discount to peers2025 Trade Ideas & Free Safe Capital Growth Stock Tips - Улправда
Will TuHURA Biosciences Inc. stock gain from lower inflationGold Moves & High Accuracy Swing Trade Signals - Улправда
Can TuHURA Biosciences Inc. stock reach $100 price targetPortfolio Update Summary & High Accuracy Trade Signal Alerts - Улправда
Aug Retail: How TuHURA Biosciences Inc. stock compares to industry benchmarksWeekly Profit Recap & Consistent Return Strategy Ideas - Улправда
Can TuHURA Biosciences Inc. (PL3) stock expand revenue streams2025 Breakouts & Breakdowns & Stepwise Trade Signal Implementation - Улправда
How TuHURA Biosciences Inc. stock compares to industry benchmarksTrade Ideas & Consistent Growth Equity Picks - Улправда
Will TuHURA Biosciences Inc. stock outperform Nasdaq indexPortfolio Performance Report & Capital Efficiency Focused Ideas - Улправда
Will TuHURA Biosciences Inc. stock deliver shareholder valueTrade Volume Report & Free Expert Approved Momentum Trade Ideas - Улправда
Is TuHURA Biosciences Inc. (PL3) stock a top pick for value investors2025 Trading Recap & Stepwise Trade Signal Implementation - Улправда
Can TuHURA Biosciences Inc. stock sustain free cash flow growth2025 Stock Rankings & Weekly High Potential Stock Alerts - DonanımHaber
Can TuHURA Biosciences Inc. stock weather global recessionWeekly Loss Report & Growth Focused Stock Reports - Улправда
TuHURA Biosciences Earnings Notes - Trefis
Bull Run: Will TuHURA Biosciences Inc. stock benefit from green energy trendsPortfolio Performance Report & Risk Controlled Stock Pick Alerts - Улправда
Rate Hike: Can TuHURA Biosciences Inc. (PL3) stock expand revenue streamsCEO Change & Weekly Top Gainers Alerts - Улправда
[Form 4] TuHURA Biosciences, Inc./NV Insider Trading Activity - Stock Titan
TuHURA Biosciences, Inc. (HURA) CEO discloses 3.4M option grant terms in filing - Stock Titan
TuHURA Biosciences, Inc. (NASDAQ:HURA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
TuHURA Biosciences, Inc. (NASDAQ:HURA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
TuHURA Biosciences Announces Its Release of Kintara's Contingent Value Right (CVR) as Kintara's REM-001 Meets Primary Safety Endpoint Achieving Contractual Milestone - 富途牛牛
TuHURA Biosciences announces release of Kintara’s CVR - TipRanks
TuHURA to release shares to Kintara CVR holders as trial meets endpoint - Investing.com Nigeria
TuHURA to release shares to Kintara CVR holders as trial meets endpoint By Investing.com - Investing.com South Africa
Tuhura Biosciences releases Kintara CVR after safety milestone - marketscreener.com
TuHURA Biosciences (NASDAQ:HURA) Rating Lowered to Sell at Wall Street Zen - MarketBeat
TuHURA Biosciences provides corporate update after $15.6M financing By Investing.com - Investing.com South Africa
TuHURA Biosciences Provides Corporate Update Following Recent Financing - Sahm
TuHURA Biosciences provides corporate update after $15.6M financing - Investing.com
TuHURA Biosciences Announces Securities Purchase Agreement - TipRanks
Big Drops For Top Wealth, TuHURA Biosciences, And AutoZone - Finimize
TuHURA Biosciences presents research on potential role of DOR at ASH - MSN
Top US Stock Market Losers Today (December 9, 2025): HURA, Phreesia, Virgin Galactic, SLM, Gogo and More - ts2.tech
TuHURA Biosciences announces $15.6M registered direct offering - TipRanks
TuHURA Biosciences plunges after $15.6 million direct stock deal - TradingView — Track All Markets
TuHURA Biosciences announces $15.6 million registered direct offering - Investing.com
Tuhura Biosciences Inc (HURA) 재무 분석
Tuhura Biosciences Inc (HURA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
28.63%
자본화:
|
볼륨(24시간):